How effective is targeted therapy for leukaemia?

Leukaemia is a group of blood cancers rather than one single disease. Some leukaemia cells contain an altered gene or protein that drives abnormal blood-cell production. A targeted medicine can block that specific signal, helping reduce the abnormal cells and allowing healthier blood formation to recover. The usefulness of the treatment depends first on whether the relevant target is present.

Doctors also consider whether the leukaemia is newly diagnosed, returning, or resistant to earlier treatment. Blood counts, examination, symptoms, and tests of the bone marrow or blood help show how the disease is responding. A response may need to be maintained with ongoing treatment, and changes in the leukaemia can lead to a different medicine or combination.

Ask which molecular finding the treatment targets and how response will be measured. Take the medicine on schedule and check before starting any new prescription, over-the-counter medicine, or supplement. Attend blood-test appointments because counts can change even when you feel well.

Tell your care team about fever, chills, mouth ulcers, unusual bruising, bleeding, worsening tiredness, breathlessness, or new pain. Some targeted medicines interact with other treatments or foods, so a complete medication list is useful at every visit.

During leukaemia treatment, contact the oncology team urgently for a fever, shaking chills, new breathlessness, bleeding that does not stop, black stools, severe headache, confusion, or rapidly worsening weakness. Go to emergency care for severe breathing difficulty, collapse, or sudden neurological symptoms. Follow the personalised fever and infection instructions given by your treatment team.

What type of leukaemia do I have, and which target was found? Is the aim remission, disease control, or preparation for another treatment? Which blood or marrow tests will show response? How should I handle a missed dose? Which symptoms require immediate contact?